Journal Club (issue 7): Telmisartan for proteinuria and renal disease

Journal Club | 30 mins

This journal club covers 2 open access papers on the use of Telmisartan to lower urine protein creatinine ratio in chronic kidney disease. One of these was published at the end of 2020 cpmaring its use to Enalipril in dogs, and another back in 2015 comparing its use to Benzapril in cats. We go through the pharmacology of Telmisartan and the theoretical advantages of an angiotensin II receptor inhibitor over an angiotensin converting enzyme (ACE) inhibitor. We cover how these studies were performed and how they add to the current literature and may change the way we treat cases of Chronic kidney disease with elevated UPCs.

Meet the speakers

Liz Bode

Director, Cardiology Specialist

Liz graduated from the University of Liverpool in 2006. After spending some time carrying out voluntary work with SPANA, Liz took up a job in mixed practice in East Yorkshire. Shortly after this, Liz completed an internship at the University of Cambridge and solidified her love for all things cardio. She subsequently embarked on a PhD at the University of Manchester looking at cellular calcium handling in heart failure and ageing and was awarded her doctorate in 2013. After another spell in small animal practice Liz completed her residency in cardiology at the University of Edinburgh in 2017. Following her residency she worked at the University of Liverpool as a senior lecturer in small animal cardiology. More recently, she was awarded Fellowship of the Higher Education Academy and has taken on the role of Module Co-ordinator for the CertAVP cardiology modules at the University of Liverpool. She currently works at Chestergates Veterinary Specialists in the UK.

already purchased this webinar? login to your vtx account for access

check out all our other webinars webinars